TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

The quest for more effective cancer radiotherapy continues apace, with Telix Pharmaceuticals (ASX:TLX) today reporting “encouraging” preliminary results from its phase II study to treat recurrent high ...

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment ...

Magnetism offers extremely promising perspectives in biology, particularly in mechanobiology and for various biomedical ...

The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.

Dead Cells has a lot of weapons, making it perfect for a tier list ranking every weapon. Throughout the game, you'll come across melee weapons, ranged weapons, traps, turrets, and even grenades, each ...

In the keynote talk, Dr Crystal Mackall from Stanford University presented data from the ongoing Phase I, open-label, single-centre clinical trial of GD2-CAR cells in diffuse midline gliomas (DMG) and ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Researchers have performed the first known ...

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like cells able to regenerate retinal tissue and support visual recovery.